- Home
- CGNT vs SLP Comparison
CGNT vs SLP Comparison
Compare CGNT & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGNT
- SLP
- Stock Information
- Founded
- CGNT 2020
- SLP 1996
- Country
- CGNT Israel
- SLP United States
- Employees
- CGNT N/A
- SLP N/A
- Industry
- CGNT Computer Software: Prepackaged Software
- SLP EDP Services
- Sector
- CGNT Technology
- SLP Technology
- Exchange
- CGNT Nasdaq
- SLP Nasdaq
- Market Cap
- CGNT 669.2M
- SLP 675.9M
- IPO Year
- CGNT N/A
- SLP 1997
- Fundamental
- Price
- CGNT $9.30
- SLP $17.02
- Analyst Decision
- CGNT Hold
- SLP Buy
- Analyst Count
- CGNT 1
- SLP 7
- Target Price
- CGNT N/A
- SLP $40.40
- AVG Volume (30 Days)
- CGNT 455.6K
- SLP 579.6K
- Earning Date
- CGNT 06-11-2025
- SLP 07-14-2025
- Dividend Yield
- CGNT N/A
- SLP 0.35%
- EPS Growth
- CGNT N/A
- SLP N/A
- EPS
- CGNT N/A
- SLP 0.36
- Revenue
- CGNT $363,466,000.00
- SLP $78,564,000.00
- Revenue This Year
- CGNT $14.94
- SLP $27.66
- Revenue Next Year
- CGNT $9.57
- SLP $6.75
- P/E Ratio
- CGNT N/A
- SLP $47.93
- Revenue Growth
- CGNT 12.58
- SLP 21.49
- 52 Week Low
- CGNT $6.21
- SLP $16.72
- 52 Week High
- CGNT $11.66
- SLP $49.05
- Technical
- Relative Strength Index (RSI)
- CGNT 42.17
- SLP 18.92
- Support Level
- CGNT $8.73
- SLP $16.72
- Resistance Level
- CGNT $9.40
- SLP $28.65
- Average True Range (ATR)
- CGNT 0.42
- SLP 1.19
- MACD
- CGNT -0.12
- SLP -0.53
- Stochastic Oscillator
- CGNT 21.92
- SLP 3.35
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.